Search Results - "Slats, Diane"
-
1
Hourly analysis of cerebrospinal fluid glucose shows large diurnal fluctuations
Published in Journal of cerebral blood flow and metabolism (01-05-2016)“…Cerebrospinal fluid analysis is important in the diagnostics of many neurological disorders. Since the influence of food intake on the cerebrospinal fluid…”
Get full text
Journal Article -
2
Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer’s Disease in Clinical Practice: An Illustration with 3 Case Reports
Published in Case reports in neurology (24-02-2010)“…Analysis of the brain specific biomarkers amyloid β 42 (Aβ 42 ) and total tau (t-tau) protein in cerebrospinal fluid (CSF) has a sensitivity and specificity of…”
Get full text
Journal Article -
3
Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: Focus on the role of hypocretin and melatonin
Published in Ageing research reviews (01-01-2013)“…Highlights ► AD pathology leads to sleep disturbances and circadian disruptions. ► Sleep disturbances have a negative influence on the quality of life of…”
Get full text
Journal Article -
4
I46 Polypharmacy in patients with advanced huntington’s disease residing in a nursing home
Published in Journal of neurology, neurosurgery and psychiatry (01-09-2016)“…BackgroundPatients with late-stage Huntington’s disease (HD) are often treated with a variety of drugs. However, especially psychotropic medication increases…”
Get full text
Journal Article -
5
Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers
Published in Neurobiology of aging (01-04-2012)“…Abstract Large hour-to-hour variability has previously been demonstrated in the cerebrospinal fluid (CSF) concentrations of Alzheimer's disease (AD) biomarkers…”
Get full text
Journal Article -
6
CSF I+/--synuclein concentrations do not fluctuate over hours and are not correlated to amyloid I super(2) in humans
Published in Neuroscience letters (31-10-2011)“…Reports on the value of cerebrospinal fluid (CSF) I+/--synuclein as a biomarker for dementia with Lewy bodies and Parkinson disease are contradicting. This may…”
Get full text
Journal Article -
7
An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter
Published in Alzheimer's research & therapy (29-07-2015)“…Amyloid-β (Aβ) has been investigated as a diagnostic biomarker and therapeutic drug target. Recent studies found that cerebrospinal fluid (CSF) Aβ fluctuates…”
Get full text
Journal Article -
8
CSF α-synuclein concentrations do not fluctuate over hours and are not correlated to amyloid β in humans
Published in Neuroscience letters (31-10-2011)“…► CSF α-synuclein concentrations do not display sinusoidal fluctuations. ► An interaction between Aβ and α-synuclein is not observed in their CSF…”
Get full text
Journal Article -
9
An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-[beta] concentrations collected by lumbar puncture and indwelling lumbar catheter
Published in Alzheimer's research & therapy (29-07-2015)“…Introduction Amyloid-[beta] (A[beta]) has been investigated as a diagnostic biomarker and therapeutic drug target. Recent studies found that cerebrospinal…”
Get full text
Journal Article -
10
O1‐04‐02: An assessment of variability in CSF biomarkers in clinical experimental models: a meta‐analysis
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article -
11
An assessment of variability in CSF biomarkers in clinical experimental models: a meta-analysis
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article -
12
O3‐03‐07: Hourly variability of cerebrospinal fluid biomarkers in Alzheimer patients and healthy elderly controls
Published in Alzheimer's & dementia (01-07-2010)Get full text
Journal Article -
13
P3‐003: Cerebrospinal fluid amyloid beta40 and the amyloid beta42/40 ratio in differentiating Alzheimer's disease from other dementias
Published in Alzheimer's & dementia (01-07-2009)Get full text
Journal Article -
14
Cerebrospinal fluid amyloid beta40 and the amyloid beta42/40 ratio in differentiating Alzheimer's disease from other dementias
Published in Alzheimer's & dementia (01-07-2009)Get full text
Journal Article -
15
P3‐003: Cerebrospinal fluid amyloid beta 40 and the amyloid beta 42/40 ratio in differentiating Alzheimer's disease from other dementias
Published in Alzheimer's & dementia (01-07-2009)Get full text
Journal Article -
16
Cerebrospinal Fluid Tau and Amyloid β Proteins Do Not Correlate With Cognitive Functioning in Cognitively Impaired Memory Clinic Patients
Published in CNS spectrums (01-09-2010)“…ABSTRACT Objective : The aim of this study was to investigate the influence of cerebrospinal fluid (CSF), amyloid β 42 (Aβ 42 ), phosphorylated tau 181…”
Get full text
Journal Article -
17
Hourly variability of cerebrospinal fluid biomarkers in Alzheimer patients and healthy elderly controls
Published in Alzheimer's & dementia (01-07-2010)Get full text
Journal Article -
18
O3‐04‐08: Cerebral vascular encephalopathy causes decreased cerebrospinal Aβ concentrations
Published in Alzheimer's & dementia (01-07-2009)Get full text
Journal Article -
19
Cerebral vascular encephalopathy causes decreased cerebrospinal Aβ concentrations
Published in Alzheimer's & dementia (01-07-2009)Get full text
Journal Article -
20
O3‐04‐08: Cerebral vascular encephalopathy causes decreased cerebrospinal Aβ concentrations
Published in Alzheimer's & dementia (01-07-2009)Get full text
Journal Article